News

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the ...
The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...
USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...
Despite promising glioblastoma trial results, Northwest Biotherapeutics faces financial instability, heavy dilution, and an ...
New insights into the mechanisms that cause more severe cases of schistosomiasis - a disease caused by parasitic worms and ...
Vaccinex (VCNX) will present exciting new data characterizing the unique mechanism of pepinemab to enhance immune responses to checkpoint ...
With 26.6% of the European market share in 2022, the U.K. is recognized as a lucrative market for cell therapy manufacturing. Support from regulatory bodies like the European Medicines Agency (EMA) ...
The immune system is comprised of various cells that work in concert to fight off disease. The two immune responses, innate and adaptive, are orchestrated | Immunology ...
Food allergies are slowly increasing within first world countries. According to the National Institute of Allergy and ...
A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...
A new study led by researchers at NYU Langone Health has revealed that a special group of cells found in mouse intestines ...